Approval · Notice of Compliance 16178 · 2014
VAN-DONEPEZIL: Notice of Compliance 16178
Issued October 14, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16178
- Date
- October 14, 2014
- Company
- Vanc Pharmaceuticals IncRichmond, British Columbia, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Cholinesterase inhibitor
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAN-DONEPEZIL | 02426943 | Cancelled Post Market |
| VAN-DONEPEZIL | 02426951 | Cancelled Post Market |
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB